JUN, HYUNGJIN,全亨珍,KI, SO YOUNG,奇小映,LEE, KEUNHO,李根昊,JUNG, JIN WOO,郑珍佑,鄭珍祐,KIM, DONG HYUN,金东炫,金東炫,PARK, CHI HYE,朴芝彗,BAK, HYOUNG ROK,朴馨绿,朴馨綠,RYU, SHIN-YOUNG,柳信永,LEE, JU HYUN,李柱昡,L
申请号：
TW109101070
公开号：
TW202019891A
申请日:
2018.07.20
申请国别(地区):
TW
年份:
2020
代理人:
摘要：
The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.本揭示內容涉及用於預防或治療非酒精性脂肪肝病或血脂異常之醫藥組成物，其包含胺烷基苯並硫氮呯衍生物或其醫藥上可接受之鹽作為活性成分。
